Abstract:The authors discover that FBXO7 confers mesenchymal properties and chemoresistance in glioblastoma. FBXO7 upregulation in mesenchymal glioblastoma stabilizes Rbfox2 through K63‐linked ubiquitination after its arginine dimethylation by PRMT5, and thus controls Rbfox2‐mediated splicing of mesenchymal genes, resulting in glioblastoma stem cell self‐renewal, mesenchymal transformation, and chemoresistance. Targeting the FBXO7‐Rbfox2 axis represents a potential strategy for glioblastoma treatment. Mesenchymal glioblastoma (GBM) is highly resistant to radio‐and chemotherapy and correlates with worse survival outcomes in GBM patients; however, the underlying mechanism determining the mesenchymal phenotype remains largely unclear. Herein, it is revealed that FBXO7, a substrate‐recognition component of the SCF complex implicated in the pathogenesis of Parkinson's disease, confers mesenchymal properties and chemoresistance in GBM by controlling Rbfox2‐mediated alternative splicing. Specifically, FBXO7 ubiquitinates Rbfox2 Lys249 through K63‐linked ubiquitin chains upon arginine dimethylation at Arg341 and Arg441 by PRMT5, leading to Rbfox2 stabilization. FBXO7 controls Rbfox2‐mediated splicing of mesenchymal genes, including FoxM1, Mta1, and Postn. FBXO7‐induced exon Va inclusion of FoxM1 promotes FoxM1 phosphorylation by MEK1 and nuclear translocation, thereby upregulates CD44, CD9, and ID1 levels, resulting in GBM stem cell self‐renewal and mesenchymal transformation. Moreover, FBXO7 is stabilized by temozolomide, and FBXO7 depletion sensitizes tumor xenografts in mice to chemotherapy. The findings demonstrate that the FBXO7‐Rbfox2 axis‐mediated splicing contributes to mesenchymal transformation and tumorigenesis, and targeting FBXO7 represents a potential strategy for GBM treatment.

Loss of FBXW7 Correlates with Increased IDH1 Expression in Glioma and Enhances IDH1-Mutant Cancer Cell Sensitivity to Radiation

FBXW7 inactivation induces cellular senescence via accumulation of p53

Functional Characterization of FBXL7 As a Novel Player in Human Cancers

FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7

FBXW7 Confers Radiation Survival by Targeting P53 for Degradation

Clinical significance of FBXW7 loss of function in human cancers

FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.

Pivotal Role of FBXW4 in Glioma Progression and Prognosis

Data from FBW7 (F-Box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the C-Myc/txnip (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination

FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy

FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2‐Mediated Alternative Splicing

Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair

IGFBP7 Plays a Potential Tumor Suppressor Role Against Colorectal Carcinogenesis with Its Expression Associated with DNA Hypomethylation of Exon 1

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase

Comprehensive characterization of FBXW7 mutational and clinicopathological profiles in human colorectal cancers

Biallelic FBXW7 knockout induces AKAP8-mediated DNA damage in neighbouring wildtype cells

FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells

Loss of FBXO31-mediated γH2AX foci formation impairs initiation of NHEJ and HR repair pathways, and sensitizes breast cancer to therapy

FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth

Expression Profiling Reveals Transcriptional Regulation by Fbxw7/Mtor Pathway in Radiation-Induced Mouse Thymic Lymphomas